Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3091268 Target Snapshot

Nuclear receptor ROR-beta · SINGLE PROTEIN · Homo sapiens

474Compounds
89Assays
2Approved Drugs
480.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q92753. Use UniProt Q92753 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q92753 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Nuclear receptor ROR-beta as ChEMBL target CHEMBL3091268, mapped to UniProt Q92753. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Nuclear receptor ROR-beta
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3091268
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q92753
Nuclear receptor ROR-beta
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Nuclear receptor ROR-beta is the right protein anchor across sources, using UniProt Q92753 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNuclear receptor ROR-beta
UniProt AccessionQ92753
Component TypeProtein
Sequence Length470 aa

Nuclear receptor ROR-beta

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Nuclear receptor ROR-beta, mapped to UniProt Q92753. Sequence length is 470 aa.

Mapped IDQ92753
Review nameNuclear receptor ROR-beta
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase I
Assay Mix

Activity Type Distribution

IC50219.0
KI14.0
EC50108.0
KD139.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL38 9.82 IC50 0.15 Approved
CHEMBL4129790 8.48 Kd 3.3 Preclinical
CHEMBL4128427 8.47 IC50 3.4 Preclinical
CHEMBL4130294 8.33 Kd 4.7 Preclinical
CHEMBL4128427 8.04 Kd 9.1 Preclinical
CHEMBL4126690 8.0 Kd 10.0 Preclinical
CHEMBL4128042 7.89 Kd 13.0 Preclinical
CHEMBL4130294 7.89 IC50 13.0 Preclinical
CHEMBL4292343 7.82 IC50 15.0 Preclinical
CHEMBL4129790 7.8 IC50 16.0 Preclinical
Distribution

pChEMBL Value Distribution

65
5.0
58
5.5
36
6.0
35
6.5
19
7.0
7
7.5
5
8.0
0
8.5
0
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

TRETINOIN
CHEMBL38
Approved 1971
Assay Landscape

Assay Landscape

89
Total Assays
264
Tested Compounds
2
Assay Types
Binding — 86 assays, 264 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 46 79 5.8
single protein format 32 96 5.4
assay format 8 89 6.3
Functional — 3 assays, 3 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 3 5.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine